Table 21:
Resource Item | Probability | Total Cost, $a | Data Source |
---|---|---|---|
Biological Complications | |||
Pocket pain with infectionb | 0.06b | — | Van Buyten et al, 201362 |
Deep infection with hospitalizationb | 0.048b | — | Van Buyten et al, 201362 |
Initial consult | — | 58.25 | Schedule of Benefits (CO46)73 |
Inpatient, hospitalization (3-day hospital stay) | — | 4,635.71 | Kumar and Bishop, 200965 |
Operation, explanation | — | 306.00 | Schedule of Benefits (N531)73 |
Additional consult | — | 58.25 | Schedule of Benefits (CO43)73 |
Intravenous antibiotic therapy | — | 1,069.35 | Kumar and Bishop, 200965 |
Home care nurse | — | 3,136.12 | Kumar and Bishop, 200965 |
Total cost (deep infection)b | — | 9,263.68c | — |
Hardware-Related Complications | |||
Lead fracture or lead migration requiring explanation | 0.072d | 6,901.17 | Van Buyten et al, 201362; Deer et al, 201416 Reoperation, lead replacement (Kumar and Bishop, 200965) |
Device malfunction and removal | 0.02 | 7,285.36 | Van Buyten et al, 201761 Reoperation, device replacement (Kumar and Bishop, 200965) |
All costs are reported in 2018 Canadian dollars.
The costs of pocket pain with infection or deep infection were assumed to be the same.
Given the specific design of the Freedom SCS system, the pocket pain and infection complication rates were not applicable and were not accounted for in the estimates of the procedure costs related to this device.